(Press-News.org) For the first time, researchers have estimated the daily dose of radiotherapy that could be wasted in compensating for cancer cell growth that occurs overnight and during weekends in patients with early breast cancer.
In research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Monday), Professor John Yarnold will say that, until now, there has been contradictory evidence as to whether gaps between radiotherapy treatments, for instance overnight or at weekends, makes any difference to the overall effectiveness of radiotherapy on breast cancer, and, if it does make a difference, why that could be.
"Traditionally, breast cancer has not been regarded as a fast growing cancer, unlike some other cancer types, but our research now suggests that a significant part of the daily radiotherapy curative dose is 'used up' in compensating for tumour growth overnight and over weekends. We have estimated that the amount of radiotherapy dose that is used up in this way corresponds to approximately 0.60 Gray (Gy) [2] per day," says Prof Yarnold, who is Professor of Clinical Oncology at The Institute of Cancer Research, London, and Honorary Consultant at the Royal Marsden NHS Foundation Trust (London, UK).
"This is the first numerical estimate to suggest that the duration of a course of radiotherapy has an effect on local cancer cure for patients with early breast cancer. The results of our analysis are hypothesis-generating; they offer an explanation as to why prolonged radiotherapy schedules may allow cancer cells to fight back, and suggest that breast cancer cell growth rates after surgery are higher than historically assumed. If confirmed, it means that current trends to deliver shorter radiotherapy schedules are likely to bear fruit in the future. However, I should emphasise that current schedules delivered over five weeks or more remain highly effective, and patients should follow recommendations from their specialists."
Radiotherapy is normally given as a series of treatments over a number of weeks in order to destroy any remaining cancer cells in the breast, chest wall or underarm area after surgery, and to reduce the risk of the cancer recurring in the same breast, while, at the same time, minimising harm to the healthy tissues.
Prof Yarnold and Ms Jo Haviland, a senior statistician at The Institute of Cancer Research (ICR) Clinical Trials and Statistics Unit (CTSU) based their research on the Standardisation of Breast Radiotherapy (START) trials (START Pilot, START A and START B), which have been evaluating the effects of giving shorter radiotherapy schedules after surgery for early breast cancer patients in the UK since 1986. [3]
The researchers used data from 5,861 UK patients who were enrolled between 1986 and 2002 into the three START randomised clinical trials that compared different schedules for delivering radiotherapy. The START Pilot and START A trials compared the international standard of giving a total of 50 Gy in 25 daily doses of 2.0 Gy over five weeks versus two other schedules of slightly higher daily doses of 3.0.3 Gy over the same time period. The START B trial compared the international standard (50 Gy in 25 daily doses of 2.0 Gy over five weeks) with a shorter schedule giving a total of 40 Gy in 15 daily doses of 2.67 Gy over three weeks. After a follow-up period of ten years, the three-week schedule was shown to be as good as the five-week schedule at preventing the cancer from recurring in the same breast and has since been adopted as the standard in the UK. In terms of safety, the three-week schedule was gentler on the normal tissues, with fewer late side-effects.
Using the data from these trials, the researchers then estimated the effect of overall radiotherapy treatment time on the risk of the cancer recurring, comparing the three-week schedule with the five-week schedules. They used a statistical model that took into account the total dose, the size of the daily dose, the length of time over which the radiotherapy was given, and factors known to be associated with the risk of the cancer recurring in the same breast. They found that approximately 0.60 Gy of the daily radiotherapy dose was being wasted during the five-week treatment schedules to compensate for cancer cells growing.
"This suggests that a shorter one-week radiotherapy schedule, replacing the five to seven-week schedules that were more usual in the past, may be more effective against breast cancer recurrence and reduce the chances of side-effects on the surrounding normal tissues. In addition, shorter treatment schedules would be more convenient for patients, with benefits including fewer trips to the hospital, and also highly cost-effective for health services," says Prof Yarnold.
Future work will investigate whether reducing the overall treatment time further is as safe and as effective as the current three-week schedule which has been standard practice in the UK since 2009, following publication of the five-year results from the START A and START B trials.
"The UK FAST Forward phase III trial is an example of this research, comparing the current UK standard three-week schedule with two radiotherapy dose levels of a one-week schedule in women with early breast cancer. This trial is well on the way to recruiting 4000 women," he will conclude.
President of ECCO, Professor Cornelis van de Velde, commented: "This is important research that suggests that the overall treatment time with radiotherapy could make a difference to outcomes for women with early breast cancer. If further investigations confirm that a shorter radiotherapy schedule is as effective as the current standard of care, it will be another step towards making treatments easier and more bearable for patients, and possibly cheaper for healthcare services."
###
[1] The 2013 European Cancer Congress is the 17th congress of the European CanCer Organisation (ECCO), the 38th congress of the European Society for Medical Oncology (ESMO) and the 32nd congress of European Society for Therapeutic Radiology and Oncology (ESTRO).
[2] One Gray is the absorption of one joule of energy, in the form of ionising radiation, per kilogram of matter.
[3] The START trials were co-ordinated by the Cancer-Research UK-funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU), and represent a long-term partnership between Prof Yarnold as the clinical lead and ICR-CTSU as an NCRN accredited/UKCRC Registered Clinical Trials Unit with a strong interest in radiotherapy trials.
[4] This work was funded by Cancer Research UK, UK Medical Research Council and UK Department of Health.
First estimate of radiotherapy dose wasted in compensating for between-treatment tumor growth
2013-09-30
ELSE PRESS RELEASES FROM THIS DATE:
Do black holes have hair?
2013-09-30
A black hole. A simple and clear concept, at least according to the hypothesis by Roy Kerr, who in 1963 proposed a "clean" black hole model, which is the current theoretical paradigm. From theory to reality things may be quite different. According to a new research carried out by a group of scientists that includes Thomas Sotiriou, a physicist of the International School for Advanced Studies (SISSA) of Trieste, black holes may be much "dirtier" than what Kerr believed.
According to the traditional model, black holes are defined by only two quantities: mass and angular ...
The immune system benefits from life in the countryside
2013-09-30
Adults who move to farming areas where they experience a wider range of environmental exposures than in cities may reduce the symptoms of their hypersensitivities and allergies considerably. This is the result of new research from Aarhus University.
This pioneering result was recently published online in the esteemed periodical, The Journal of Allergy and Clinical Immunology in an article entitled "Become a farmer and avoid new allergic sensitization: Adult farming exposures protect against new-onset atopic sensitization".
The immune systems of people who work in farming ...
PV production grows despite a crisis-driven decline in investment
2013-09-30
Global production of photovoltaic (PV) cells grew by 10% in 2012 in comparison to 2011 despite a 9% decline in solar energy investments according to the annual "PV Status Report" released by the European Commission's Joint Research Centre. Europe remained a leader in newly installed capacities accounting for 51.7% (16.8 GW) of the 30 GW installed worldwide.
Abundant solar resources in combination with zero emissions from solar installations have attributed to PV energy systems a key role in the transition to a low carbon energy supply. This potential has driven development ...
Research shows how aspirin may act on blood platelets to improve survival in colon cancer patients
2013-09-30
Researchers believe they have discovered how aspirin improves survival in patients diagnosed with colon cancer, the 2013 European Cancer Congress (ECC2013) [1] heard today (Monday).
Although previous research has shown that taking low dose aspirin after being diagnosed with colon cancer improves patient outcome, the reasons why this happens remain unknown. The new research has shown that aspirin improves outcome in patients whose tumour cells express a specific protein on their surface; the protein is known as Human Leukocyte Antigen class I (HLA class I), a cell-surface ...
The world's sharpest X-ray beam shines at DESY
2013-09-30
The world's sharpest X-ray beam shines at DESY. At the X-ray light source PETRA III, scientists from Göttingen generated a beam with a diameter of barely 5 nanometres – this is ten thousand times thinner than a human hair. This fine beam of X-ray light allows focusing on smallest details. The research groups of Professor Tim Salditt from the Institute of X-ray Physics and of Professor Hans-Ulrich Krebs from the Institute of Materials Physics of the University of Göttingen published their work in the research journal Optics Express.
High-energy (hard) X-ray light cannot ...
Cocaine use may increase HIV vulnerability
2013-09-30
Bethesda, MD -- Cocaine use may increase one's vulnerability to HIV infection, according to a new research report published in the Journal of Leukocyte Biology. In the report, scientists show that cocaine alters immune cells, called "quiescent CD4 T cells," to render them more susceptible to the virus, and at the same time, to allow for increased proliferation of the virus.
"We ultimately hope that our studies will provide a better understanding of how drugs of abuse impact how our body defends itself against disease," said Dimitrios N. Vatakis, Ph.D., the study's senior ...
Researchers ferret out function of autism gene
2013-09-30
Researchers say it's clear that some cases of autism are hereditary, but have struggled to draw direct links between the condition and particular genes. Now a team at the Johns Hopkins University School of Medicine, Tel Aviv University and Technion-Israel Institute of Technology has devised a process for connecting a suspect gene to its function in autism.
In a report in the Sept. 25 issue of Nature Communications, the scientists say mutations in one such autism-linked gene, dubbed NHE9, which is involved in transporting substances in and out of structures within the ...
Biological therapy with cediranib improves survival in women with recurrent ovarian cancer
2013-09-30
Women with ovarian cancer that has recurred after chemotherapy have survived for longer after treatment with a biological therapy called cediranib, according to new results to be presented today (Monday) at the 2013 European Cancer Congress (ECC2013) [1].
Cediranib, which is taken in pill form, is an inhibitor of a cell signalling process involved in formation of tumour blood vessels, essential for tumour growth, and it is the first oral inhibitor of its kind to show an improvement in the time before patients' disease progresses and in overall survival. The drug is a ...
Olympians say poor oral health is impairing performance
2013-09-30
Many of the elite sportsmen and women who competed at the London 2012 Olympic Games had poor levels of oral health similar to those experienced by the most disadvantaged populations. 18 per cent of athletes surveyed said their oral health was having a negative impact on their performance.
The research, which was led by Professor Ian Needleman at the UCL Eastman Dental Institute, is published in the British Journal of Sports Medicine.
The researchers recruited 302 athletes to take part in the study at the Dental Clinic in the London 2012 athletes' village. The athletes ...
Quantum computers: Trust is good, proof is better
2013-09-30
This news release is available in German. The harnessing of quantum phenomena, such as superposition and entanglement, holds great promise for constructing future supercomputers using quantum technology. One huge advantage of such quantum computers is that they are capable of performing a variety of tasks much quicker than their conventional counterparts. The use of quantum computers for these purposes raises a significant challenge: how can one verify the results provided by a quantum computer?
It is only recently that theoretical developments have provided methods ...